The association between hyaluronic acid (HA) (the ligand of CD44) and CD44 was enhanced by HAS2 in TAMs obtained from patients with head and neck squamous cell carcinoma, as demonstrated by Gomez’s group. This evidence concerns the gene CD44 and head and neck squamous cell carcinoma.